KR20230171936A - 지속 작용성 성장 호르몬 폴리펩타이드를 투여하는 방법 - Google Patents

지속 작용성 성장 호르몬 폴리펩타이드를 투여하는 방법 Download PDF

Info

Publication number
KR20230171936A
KR20230171936A KR1020237035239A KR20237035239A KR20230171936A KR 20230171936 A KR20230171936 A KR 20230171936A KR 1020237035239 A KR1020237035239 A KR 1020237035239A KR 20237035239 A KR20237035239 A KR 20237035239A KR 20230171936 A KR20230171936 A KR 20230171936A
Authority
KR
South Korea
Prior art keywords
subject
long
rhgh
acting
dose level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237035239A
Other languages
English (en)
Korean (ko)
Inventor
호세 프란치스코 카라
알렉산드라 파스트라크
스리니바스 라오 발루리
마이클 폴 와인라치
Original Assignee
화이자 인코포레이티드
옵코 바이오로직스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 인코포레이티드, 옵코 바이오로직스 리미티드 filed Critical 화이자 인코포레이티드
Publication of KR20230171936A publication Critical patent/KR20230171936A/ko
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Diabetes (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
KR1020237035239A 2021-03-19 2022-03-17 지속 작용성 성장 호르몬 폴리펩타이드를 투여하는 방법 Pending KR20230171936A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163163504P 2021-03-19 2021-03-19
US63/163,504 2021-03-19
US202163272417P 2021-10-27 2021-10-27
US63/272,417 2021-10-27
PCT/US2022/020804 WO2022197961A1 (en) 2021-03-19 2022-03-17 Methods of administering long-acting growth hormone polypeptides

Publications (1)

Publication Number Publication Date
KR20230171936A true KR20230171936A (ko) 2023-12-21

Family

ID=83320806

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237035239A Pending KR20230171936A (ko) 2021-03-19 2022-03-17 지속 작용성 성장 호르몬 폴리펩타이드를 투여하는 방법

Country Status (10)

Country Link
US (1) US20240166710A1 (cg-RX-API-DMAC7.html)
EP (1) EP4308151A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022145646A (cg-RX-API-DMAC7.html)
KR (1) KR20230171936A (cg-RX-API-DMAC7.html)
AU (1) AU2022238386A1 (cg-RX-API-DMAC7.html)
BR (1) BR112023018980A2 (cg-RX-API-DMAC7.html)
CA (1) CA3214273A1 (cg-RX-API-DMAC7.html)
IL (1) IL305661A (cg-RX-API-DMAC7.html)
MX (1) MX2023010997A (cg-RX-API-DMAC7.html)
WO (1) WO2022197961A1 (cg-RX-API-DMAC7.html)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020155990A1 (en) * 2001-04-20 2002-10-24 Renasci, Inc., D/B/A Renasci Anti-Aging Center Method of optimizing growth hormone replacement
WO2009102734A1 (en) * 2008-02-11 2009-08-20 Depomed Inc. Methods for treating vasomotor symptoms using gaba analogs in a gastric retentive dosage form
US20150158926A1 (en) * 2013-10-21 2015-06-11 Opko Biologics, Ltd. Long-acting polypeptides and methods of producing and administering same
HUE050002T2 (hu) * 2013-10-21 2020-11-30 Opko Biologics Ltd Hosszan ható polipeptidek és eljárás azok elõállítására és beadására
EP4732848A3 (en) * 2014-11-21 2026-07-29 Ascendis Pharma Endocrinology Division A/S Long-acting growth hormone dosage forms
KR102527180B1 (ko) * 2014-12-10 2023-04-27 옵코 바이오로직스 리미티드 장기간 작용성 ctp-변형된 성장 호르몬 폴리펩타이드의 제조 방법
MY184625A (en) * 2014-12-10 2021-04-09 Opko Biologics Ltd Methods of producing long acting ctp-modified growth hormone polypeptides

Also Published As

Publication number Publication date
BR112023018980A2 (pt) 2023-12-05
EP4308151A4 (en) 2025-02-26
EP4308151A1 (en) 2024-01-24
WO2022197961A1 (en) 2022-09-22
CA3214273A1 (en) 2022-09-22
US20240166710A1 (en) 2024-05-23
JP2022145646A (ja) 2022-10-04
MX2023010997A (es) 2023-11-28
AU2022238386A1 (en) 2023-09-14
IL305661A (en) 2023-11-01

Similar Documents

Publication Publication Date Title
US20220241380A1 (en) Long-acting polypeptides and methods of producing and administering same
JP2017125051A (ja) Hgh−xten融合タンパク質および成長ホルモン欠乏症の処置におけるその使用
JP2016514132A (ja) ヒト成長ホルモン類似体を用いた小児成長ホルモン分泌不全症の治療
KR20150106887A (ko) 인간 성장 호르몬과 알부민의 융합, 이의 제형 및 용도
BR112019019823A2 (pt) conjugado, composição farmacêutica para prevenir ou tratar diabetes e método para tratamento de diabetes
US20160271265A1 (en) Insulin-like growth factor mimetics for use in therapy
TWI777407B (zh) 長效型多肽及其生產和給藥的方法
CN117425490A (zh) 施用长效生长激素多肽的方法
US20240166710A1 (en) Methods of administering long-acting growth hormone polypeptides
HK40098775A (en) Methods of administering long-acting growth hormone polypeptides
TW202432577A (zh) 投與基於纖連蛋白之支架域蛋白以治療超重、肥胖及相關健康病狀
Dao et al. Human growth hormone
JP2007523196A (ja) Nt−4/5を用いて肥満または糖尿病を処置する方法
Wang et al. Tesamorelin, a human growth hormone releasing factor analogue
US20250325560A1 (en) Methods for improving muscle mass, strength, or function with a combination of testosterone and growth hormone
Dao et al. Human growth hormone
US20200000884A1 (en) Treatment of adult growth hormone deficiency with human growth hormone analogues
Luz et al. History and Current Status of Growth Hormone Treatment in Children: CC Luz, PF Collett-Solberg
Ying et al. Once-Weekly Lonapegsomatropin Was Efficacious and Well Tolerated in Chinese Children with Growth Hormone Deficiency: Results from a Phase 3 Randomized Trial
Steelman et al. Cara, CL Roland, CT Taylor, SR Valluri, and MP Wajnrajch are employees
Class et al. Patent application title: FUSION OF HUMAN GROWTH HORMONE AND ALBUMIN FORMULATION AND USES THEREOF Inventors: Kurt Brown (Narbeth, PA, US) Merav Bassan (Netanya, IL) Assignees: Teva Pharmaceutical Industries Ltd.
HK40034109A (en) Long-acting polypeptides and methods of producing and administering same
Mason 16th International Congress of Endocrinology/96th Annual Meeting and Exposition of the Endocrine Society (ICE/ENDO), Chicago, Illinois, USA-June 21-24, 2014

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20231016

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20250317

Comment text: Request for Examination of Application